Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	222.24	65.82	20.43
Graham Fair Price	39.58	60879.21	43614.78
PEG	-89.57	0.03	0.32
Price/Book	11.18	0.28	0.25
Price/Cash Flow	-52.69	0.41	-0.87
Prices/Earnings	-42.35	3.15	5.46
Price/Sales	-12.24	2.98	3.40
Price/FCF	-52.69	0.41	-0.87
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	1.82	0.96	0.94
Operating Margin	8.31	0.64	0.59
ROA	-43.51	< 0.005	< 0.005
ROE	0.01	0.02	92.86
ROIC	0.02	< 0.005	-54.13
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	3.76	0.13	2787.03
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	2.02	0.38	-81.20
EPS QOQ	0.17	0.94	452.57
FCF QOQ	-15.02	3.36	-77.61
Revenue QOQ	0.55	0.27	-50.68
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	252.73	1741.62	589.14
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.47	0.81	72.25
Quick Ratio	0.87	0.60	-31.39
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	85121.95	85557.76	0.51
Cash	32588.11	45352.07	39.17
Capex	-2.87	-36.51	-1172.07
Free Cash Flow	-24936.21	58905.43	136.22
Revenue	6389.87	8136.30	27.33
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.00	0.00	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	14.76	61.21	314.73
Naive Interpretation	Member

06 - Financial Health · Bad

Rating